Altrient Liposomal Vitamin C, 1000mg, 30 Sachets

More about Altrient Liposomal Vitamin C:

Our body doesn’t metabolize efficiently the most ordinary forms of oral Vitamin C, tablets, capsules, powders or liquids. This is because our body tightly regulates its absorption rate. This means that levels of vitamin C in the intestine may reach saturation point at as little as 200mg. In fact, the more we take in the less we absorb. Thus, very little reaches your blood stream and body cells, where it acts. Intravenous delivery of vitamin C has proven to be the most effective route for absorption, but this method is both costly and impractical.

Altrient Liposomal Vitamin C 1000mg:

• CONTRIBUTES TO THE NORMAL FUNCTION OF THE IMMUNE AND NERVOUS SYSTEM.
• TAKES PART INTO NORMAL COLLAGEN FORMATION FOR OPTIMAL SKIN FUNCTION, BLOOD VESSELS, BONES, CARTILAGE, GUMS & TEETH.
• CONTRIBUTES TO THE REDUCTION OF TIREDNESS AND FATIGUE AND TO THE PROTECTION OF CELLS FROM OXIDATIVE STRESS.

Ingredients: Deionized Water, Sodium Ascorbate, Lecithin Phospholipids (soy), natural preservative: Grain Alcohol (ethanol 12% w/w see ethanol evaporation statement), acidity regulator: Citric Acid (to achieve 6-7 PH adjustment).

Study:

If you would like to read a study on the link between liposomal vitamin C and cancer treatment, click HERE. This is from that study: “Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Others show inadequate bioavailability due to their instability in the blood or having a hydrophilic nature that limits their permeation through the cell membrane.

Therefore, entrapping antioxidants in liposomes may overcome these drawbacks. This is because liposomes have the capability to accommodate both hydrophilic and hydrophobic compounds with a considerable stability. Additionally, liposomes have the capability to accumulate at the cancer tissue passively. This is due to their small sizes, with enhanced drug delivery. Additionally, scientists can engineer liposomes with targeting moieties to increase the delivery of chemotherapeutic agents to specific tumour cells with decreased accumulation in healthy tissues. Therefore, combined use of liposomes and antioxidants, with or without chemotherapeutic agents, is an attractive strategy to combat varies tumours. “